back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-06-13 10:25 Tx date 2023-06-12 |
$FRX
Fennec Pharmaceuticals Inc. |
Brughera, Marco
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$175,600
+20,000 vol $8.78 each |
175,545 | |
| Filed 2022-06-16 09:37 Tx date 2022-06-14 |
$FRX
Fennec Pharmaceuticals Inc. |
Brughera, Marco
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$111,800
+20,000 vol $5.59 each |
155,545 | |
| Filed 2021-06-30 16:37 Tx date 2021-06-29 |
$FRX
Fennec Pharmaceuticals Inc. |
Brughera, Marco
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,400
+20,000 vol $7.52 each |
135,545 | |
| Filed 2020-08-14 08:37 Tx date 2020-08-13 |
$FRX
Fennec Pharmaceuticals Inc. |
Brughera, Marco
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$123,400
+20,000 vol $6.17 each |
115,545 | |
| Filed 2019-06-19 13:04 Tx date 2019-06-18 |
$FRX
Fennec Pharmaceuticals Inc. |
Brughera, Marco
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,200
+20,000 vol $4.26 each |
95,545 | |
| Filed 2018-06-10 Tx date 2018-06-08 |
$FRX
Fennec Pharmaceuticals Inc. |
Brughera, Marco
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$218,600
+20,000 vol $10.93 each |
75,545 | |
| Filed 2017-06-28 Tx date 2017-06-27 |
$FRX
Fennec Pharmaceuticals Inc. |
Brughera, Marco
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+20,000 vol $5.10 each |
55,545 | |
| Filed 2017-01-03 Tx date 2016-12-30 |
$FRX
Fennec Pharmaceuticals Inc. |
Brughera, Marco
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$74,999
+35,545 vol $2.11 each |
35,545 | |
| Filed 2017-01-03 Tx date 2016-08-10 |
$FRX
Fennec Pharmaceuticals Inc. |
Brughera, Marco
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-01-03 Tx date 2016-08-10 |
$FRX
Fennec Pharmaceuticals Inc. |
Brughera, Marco
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|